Boston Scientific Statistics
Total Valuation
ETR:BSX has a market cap or net worth of EUR 135.53 billion. The enterprise value is 145.48 billion.
Market Cap | 135.53B |
Enterprise Value | 145.48B |
Important Dates
The last earnings date was Wednesday, April 23, 2025.
Earnings Date | Apr 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.11% |
Shares Change (QoQ) | +0.19% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 72.09.
PE Ratio | 72.09 |
Forward PE | n/a |
PS Ratio | 8.34 |
PB Ratio | 6.53 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.39, with an EV/FCF ratio of 52.17.
EV / Earnings | 77.38 |
EV / Sales | 9.34 |
EV / EBITDA | 35.39 |
EV / EBIT | 50.53 |
EV / FCF | 52.17 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.52.
Current Ratio | 1.45 |
Quick Ratio | 0.68 |
Debt / Equity | 0.52 |
Debt / EBITDA | 2.53 |
Debt / FCF | 3.88 |
Interest Coverage | 10.21 |
Financial Efficiency
Return on equity (ROE) is 9.50% and return on invested capital (ROIC) is 6.21%.
Return on Equity (ROE) | 9.50% |
Return on Assets (ROA) | 5.28% |
Return on Invested Capital (ROIC) | 6.21% |
Return on Capital Employed (ROCE) | 9.25% |
Revenue Per Employee | 306,433 |
Profits Per Employee | 35,472 |
Employee Count | 53,000 |
Asset Turnover | 0.46 |
Inventory Turnover | 2.04 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.91% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +37.91% |
50-Day Moving Average | 90.30 |
200-Day Moving Average | 84.40 |
Relative Strength Index (RSI) | 59.55 |
Average Volume (20 Days) | 191 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, ETR:BSX had revenue of EUR 16.24 billion and earned 1.88 billion in profits. Earnings per share was 1.27.
Revenue | 16.24B |
Gross Profit | 11.12B |
Operating Income | 3.00B |
Pretax Income | 2.29B |
Net Income | 1.88B |
EBITDA | 4.20B |
EBIT | 3.00B |
Earnings Per Share (EPS) | 1.27 |
Balance Sheet
The company has 670.77 million in cash and 10.83 billion in debt, giving a net cash position of -10.16 billion.
Cash & Cash Equivalents | 670.77M |
Total Debt | 10.83B |
Net Cash | -10.16B |
Net Cash Per Share | n/a |
Equity (Book Value) | 20.77B |
Book Value Per Share | 13.89 |
Working Capital | 2.11B |
Cash Flow
In the last 12 months, operating cash flow was 3.53 billion and capital expenditures -738.31 million, giving a free cash flow of 2.79 billion.
Operating Cash Flow | 3.53B |
Capital Expenditures | -738.31M |
Free Cash Flow | 2.79B |
FCF Per Share | n/a |
Margins
Gross margin is 68.45%, with operating and profit margins of 18.49% and 11.58%.
Gross Margin | 68.45% |
Operating Margin | 18.49% |
Pretax Margin | 14.12% |
Profit Margin | 11.58% |
EBITDA Margin | 25.84% |
EBIT Margin | 18.49% |
FCF Margin | 17.17% |
Dividends & Yields
ETR:BSX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.11% |
Shareholder Yield | -1.11% |
Earnings Yield | 1.39% |
FCF Yield | 2.06% |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2.
Last Split Date | Nov 6, 2003 |
Split Type | Forward |
Split Ratio | 2 |
Scores
ETR:BSX has an Altman Z-Score of 5.13.
Altman Z-Score | 5.13 |
Piotroski F-Score | n/a |